Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$1.16 - $6.41 $5,301 - $29,293
4,570 Added 8.27%
59,833 $69,000
Q4 2022

Jan 23, 2023

BUY
$4.78 - $15.01 $129,968 - $408,121
27,190 Added 96.85%
55,263 $0
Q3 2022

Oct 25, 2022

BUY
$10.22 - $23.7 $32,346 - $75,010
3,165 Added 12.71%
28,073 $323,000
Q2 2022

Jul 26, 2022

BUY
$4.35 - $15.85 $108,349 - $394,791
24,908 New
24,908 $281,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Mendel Capital Management LLC Portfolio

Follow Mendel Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Capital Management LLC with notifications on news.